Indefinite Delivery Contract SPE2DB22D6031
- Not listed
- The Indefinite Delivery Contract SPE2DB was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp as a single-award contract vehicle with a potential value of $999,999,999. Task orders described in the IDV award various pharmaceutical products to support DLA medical logistics programs. Orders valued from $106 to $30,494.61 require delivery of prescription drugs, vaccines, and medical supplies to Amerisourcebergen's facility in Conshohocken, PA, with completion by September 29,...
- The single award Indefinite Delivery Contract SPE2DB was issued on May 19, 2022 by the Defense Logistics Agency to provide pharmaceutical products and services. With a potential value of $499,999,999, the contract utilizes no set-asides and has a period of performance through December 31, 2025. DMS Pharmaceutical Group Inc. will serve as the prime vendor for the DLA's Philadelphia branch, supplying pharmaceuticals to support Defense Department operations. The original solicitation sought a...
- The indefinite delivery contract SPE2DB was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corporation on June 8, 2022. The contract established Amerisourcebergen Drug Corporation as the prime contractor to supply pharmaceutical products and medical supplies to the Defense Logistics Agency on an as-needed basis, with a potential value of $999,999,999. Under the contract, Amerisourcebergen Drug Corporation has been issued numerous fixed-price delivery orders to supply various...
- This indefinite-delivery contract was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corporation as a single-award prime vendor for pharmaceutical products and medical supplies. The base IDV has a potential value of $999,999,999 with a period of performance through December 31, 2025. Task orders provided indicate the contractor will supply a range of pharmaceuticals to DLA customers from its Conshohocken, Pennsylvania facility, including generic and brand name medications,...
- The Indefinite Delivery Contract was awarded as a single award by the Defense Logistics Agency to DMS Pharmaceutical Group Inc. With a potential value of $499,999,999, the contract supports the Prime Vendor Pharmaceutical Branch in Philadelphia through December 31, 2025. The SPE2DB program aims to procure pharmaceutical products and services for the Defense Logistics Agency through a prime vendor arrangement. DMS Pharmaceutical Group Inc. will deliver pharmaceuticals and manage distribution to...
- The Defense Logistics Agency awarded a single-award indefinite delivery contract with a potential value of $999,999,999 to Amerisourcebergen Drug Corporation. Task orders issued against the contract call for the delivery of various pharmaceutical products and medical supplies to support DLA's worldwide logistics operations. Delivery orders provided as examples include vaccines, antibiotics, chronic disease medications, contrast agents, and other pharmaceuticals. Orders range from a few hundred...
- The federal contract IDV award SPE2DR25D3801 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, has a 30-month base period and three 30-month option periods, for a total potential period of performance through December 2036. The IDC serves as a primary vehicle for...
- The Indefinite Delivery Contract SPE2DR25D2103 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, aims to establish a Pharmaceutical Prime Vendor Global Program Generation V to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency (DHA), U.S. Coast...
- The federal contract IDV award SPE2DR25D1205 is a $999,999,999 Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a 30-month base period with three 30-month option periods, running through December 2036. The IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...
- Amerisourcebergen Drug Corp has received a single award indefinite delivery contract from the Defense Logistics Agency under the SPE2DX program. With a potential value of $999,999,999, the contract aims to procure pharmaceutical products and related distribution services in support of DLA Troop Support Medical facilities through December 2025. No set-aside designations were applied. Performance will include Amerisourcebergen's headquarters in Conshohocken, Pennsylvania. As the prime...
- SPE2DB22D6031Indefinite Delivery Contract
- 7Federal Contract Awards
The Indefinite Delivery Contract SPE2DB was awarded as a single award by the Defense Logistics Agency to Amerisourcebergen Drug Corp on May 19, 2022. The contract has a potential value of $999,999,999 and a period of performance through December 31, 2025. The SPE2DB IDV aims to procure pharmaceutical products and related services for the DLA's Philadelphia branch through a prime vendor arrangement. Amerisourcebergen will serve as the prime contractor and provide pharmaceuticals to DLA Philadelphia through a vendor-managed inventory model. The IDV establishes a blanket purchase agreement and associated task orders or price lists by which DLA Philadelphia can order needed pharmaceutical stock on an as-needed basis through the end of 2025. No set-asides were applied to the award, reflecting DLA's need for an experienced pharmaceutical distributor to manage its inventory and fulfill orders from its Philadelphia branch in a timely, compliant manner. The IDV structure offers flexibility to accommodate changing pharmaceutical needs over the three-year ordering period while leveraging the prime vendor's expertise and distribution infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 5/19/22 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order SPE2DB22D6031-SPE2DB24FU7AV | Amerisourcebergen Drug Corp | $807 | 6/4/24 | 6/5/24 | 6/4/24 | |
Delivery Order SPE2DB22D6031-SPE2DB24FU7AW | Amerisourcebergen Drug Corp | $607 | 6/4/24 | 6/5/24 | 6/4/24 | |
Delivery Order SPE2DB22D6031-SPE2DB24FU7AE | Amerisourcebergen Drug Corp | $1.2k | 11/3/23 | 11/6/23 | 11/3/23 | |
Delivery Order SPE2DB22D6031-SPE2DB25FU7AE | Amerisourcebergen Drug Corp | $26 | 7/9/25 | 7/10/25 | 7/9/25 | |
Delivery Order SPE2DB22D6031-SPE2DB24FU7AX | Amerisourcebergen Drug Corp | $141 | 9/4/24 | 9/5/24 | 9/4/24 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Pharmaceutical Prime Vendor Global | SPM2DP-13-R-0007 | Defense Logistics Agency Troop Support Medical | Award Notice 1/1 | 8/20/13, 10:37 AM |